A niche blog dedicated to the issues that arise when supplementary protection certificates (SPCs) extend patents beyond their normal life -- and to the respective positions of patent owners, investors, competitors and consumers. The blog also addresses wider issues that may be of interest or use to those involved in the extension of patent rights. You can email The SPC Blog here

Monday 14 March 2011

Norwegian valsartan case goes on appeal

The SPC Blog has just learned this morning from Kaja Veel Midtbø (Wikborg Rein, Oslo) that the litigation in Norway in Novartis v Actavis concerning valsartan (noted here by The SPC Blog on 8 March) is to go on appeal.  The original judgment, from the Oslo District Court (10 February 2011) will be appealed by Actavis to the Borgarting Court of Appeal. There are two grounds of appeal -- the patent infringement issue in general and the issue specifically concerning the scope of the SPC.

Wikborg Rein (Ingvild Hanssen-Bauer) represents Actavis in this litigation.

No comments: